Multi-omics profiling, <i>in vitro</i> and <i>in vivo</i> enhancer assays dissect the <i>cis</i>-regulatory mechanisms underlying North Carolina macular dystrophy, a retinal enhanceropathy
bioRxiv (Cold Spring Harbor Laboratory)